文传商讯
Philip Morris International Announces Yearlong Exploration of Inclusion—Furthering the Company’s C
2021-03-10 07:24:36
顶尖律所ROSEN鼓励损失超过10万美元的Immunovant, Inc.（前称Health Sciences Acquisitions Corporation）
2021-03-10 07:24:36
Toshiba’s Response to Effissimo’s Proposal Is Misleading and Inadvertently Points to Further Irreg
2021-03-10 07:24:36
Vifor Pharma and Cara Therapeutics announce U.S. FDA acceptance and Priority Review of NDA for KORSU
2021-03-10 07:24:36
